🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

3 notícias encontradas para "both"
Foto: Marta Branco / Pexels
Dicas
Oil price jumps over 4% and gold slides as the US and Iran trade attacks –business live
Asian shares tumble with South Korea’s Kospi down nearly 10%Good morning, and welcome to our rolling coverage of business, the financial markets and the world economy.It’s a gloomy start to the week as attacks between the US and Iran in the Gulf continue. Tehran said it had closed the strait of Hormuz, while Donald Trump insisted the key shipping passage remained open and US officials said 20 ships were escorted through the waterway in the past 24 hours.For now, we remain hopeful that
Foto: Rino Adamo / Pexels
Dicas
Here’s how Andy Burnham can finance a reindustrialised Britain – without doing a Liz Truss | Larry Elliott
Britain’s PM-in-waiting is right that the country has been failed by 40 years of neoliberalism. There will be obstacles, but he must embrace radicalism Of all the many prime ministers who have walked through the doors of 10 Downing Street in the past decade, the one Andy Burnham resembles most is Liz Truss. Both had a view of what was going wrong with the economy. Both wanted to break with the politics of managed decline. Both had ambitious ideas for what needed to be done.Truss, of co
Foto: Mitchell Henderson / Pexels
Dicas
UK housing market downturn eases but sentiment remains ‘fragile’, surveyors say – business live
Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand